Environmental exposures are a critical risk factor for developing Parkinson’s disease. Through large population studies, more than 70 chemicals have been linked to Parkinson’s risk, including certain pesticides, pollutants and industrial solvents. Exposures to these chemicals are believed to contribute to the progressive loss of dopamine neurons in the brain.
While we know exposure to these chemicals can increase the risk of developing Parkinson’s, we are still not sure exactly how different exposures damage neurons – different toxins likely harm cells in unique ways.
Brent Ryan, PhD, from the Oxford Parkinson’s Disease Centre at the University of Oxford in England, is working with his team to screen and assess the health of two key parts of neurons — mitochondria and lysosomes — after exposure to Parkinson’s-related chemicals to understand the biological changes that lead to Parkinson’s disease.
Mitochondria and lysosomes are known as organelles, tiny structures within cells that provide important functions.
Mitochondria are the power plants of cells, turning nutrients into cellular energy.
Lysosomes are the recycling centres, processing cellular junk into raw materials for building new cellular machinery.
Both are often impaired in Parkinson’s and problems with these systems may contribute to the damage experienced by dopamine-producing brain cells.
Dr. Ryan and his team have developed a new technology called “organelle painting,” which will help explain how Parkinson’s-linked chemical exposures damage mitochondria and lysosomes.
These tools allow researchers to interpret multiple aspects of cellular health at once, generating a thorough health report for these organelles that provides a more complete picture of how mitochondria and lysosomes respond to different chemical exposures.
Dr. Ryan will take human dopamine-producing neurons grown in the laboratory, expose them to the various Parkinson’s-linked chemicals, and generate health reports to see exactly how the chemicals affected the mitochondria and lysosomes.
He will also test how different combinations of chemical lead to even greater impairments, simulating potential real-world scenarios. By understanding the precise ways in which certain chemicals damage cells, researchers can generate more specific treatments to improve PD outcomes.
All these results will be used to build a PD Toxicant-Organelle Interaction Atlas, a publicly accessible database that other researchers can use to guide their own Parkinson’s research. Dr. Ryan hopes that having such important data and methods available for everyone will accelerate the scientific community toward new breakthroughs, treatments and a cure.
Source: Parkinson’s Foundation





